Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

The perverted irony of Health Canada's Special Access Programme

Timothy K.S. Christie and Julio S.G. Montaner
CMAJ June 06, 2006 174 (12) 1746-1746-a; DOI: https://doi.org/10.1503/cmaj.1060054
Timothy K.S. Christie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio S.G. Montaner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The Oxford English Dictionary defines the word “irony” as “a state of affairs that appears perversely contrary to what one expects.” A recent description of the use of Health Canada's Special Access Programme (SAP) to obtain breast implants1 is by all means “perversely contrary” to what we expect from the SAP — or is it?

The SAP is designed for patients with serious or life-threatening conditions and who require “emergency” and/or “compassionate” access to drugs not authorized for use in Canada, when conventional therapies have “failed, are unsuitable, or are unavailable.”2

According to the news story,1 67% of SAP requests annually are for breast implant devices, and over the past 5 years, the SAP has approved over 21 000 requests for silicone implants. The cosmetic surgeons interviewed explained that “small breasts” and “slight rippling of the skin through saline implants” are the medical conditions for which implants are sought through the SAP.

In April 2005, we applied to the SAP for “emergency” access to 2 experimental drugs on behalf of 6 patients with advanced AIDS who could no longer derive a clinical benefit from the anti-HIV drugs available in Canada. SAP denied our application and all appeals.

Hence, we question the raison d'être of the SAP and its mode of operation. One of our patients died during this 10-month battle, but no one has ever died from “small breasts” or “slight rippling of the skin.” Without disparaging the difficulties experienced by women who need breast implants, we cannot contain our moral outrage at the ineffectiveness of the SAP in dealing with this truly life-threatening matter.

REFERENCES

  1. 1.↵
    Loophole allows banned silicone implants [Internet]. Global National 2006 Feb 16. Available: www.canada.com/globaltv/national/story.html?id=f4ba541d-bd2e-4302-81dd-623b8cffb33f (accessed 2006 Apr 28).
  2. 2.↵
    Special access to drugs and health products: drugs [Internet]. Ottawa: Health Canada; [updated 2005 Aug 15]. Available: www.hc-sc.gc.ca/dhp-mps/acces/drugs-drogues/index_e.html (accessed 2006 Apr 28).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 174 (12)
CMAJ
Vol. 174, Issue 12
6 Jun 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The perverted irony of Health Canada's Special Access Programme
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The perverted irony of Health Canada's Special Access Programme
Timothy K.S. Christie, Julio S.G. Montaner
CMAJ Jun 2006, 174 (12) 1746-1746-a; DOI: 10.1503/cmaj.1060054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The perverted irony of Health Canada's Special Access Programme
Timothy K.S. Christie, Julio S.G. Montaner
CMAJ Jun 2006, 174 (12) 1746-1746-a; DOI: 10.1503/cmaj.1060054
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Responding to Bill C-7
  • Benefits of nirmatrelvir–ritonavir remain unproven for some populations
  • Renalism
Show more Letters

Similar Articles

Collections

  • Topics
    • Health care coverage

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire